肌肉浸润性膀胱癌患者不同治疗方法总生存期的比较:回顾性研究。

IF 0.8 Q4 UROLOGY & NEPHROLOGY
Urologia Journal Pub Date : 2024-11-01 Epub Date: 2024-06-12 DOI:10.1177/03915603241256009
Hamid Pakmanesh, Azadeh Khajehsalimi, Mohammadamin Hesamarefi, Mohamad Reza Ebadzadeh, Azam Bazrafshan, Reza Malekpourafshar, Mahboubeh Mirzaei, Azar Daneshpajouh, Armita Shahesmaeili, Nazanin Eslami
{"title":"肌肉浸润性膀胱癌患者不同治疗方法总生存期的比较:回顾性研究。","authors":"Hamid Pakmanesh, Azadeh Khajehsalimi, Mohammadamin Hesamarefi, Mohamad Reza Ebadzadeh, Azam Bazrafshan, Reza Malekpourafshar, Mahboubeh Mirzaei, Azar Daneshpajouh, Armita Shahesmaeili, Nazanin Eslami","doi":"10.1177/03915603241256009","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Bladder-Sparing Approach was presented in patients who are not willing or not suitable for Radical Cystectomy (RC). There have been inconsistencies in the literature regarding the comparison of survival rates of these two methods. Our objective is to evaluate the survival rate of patients with muscle-invasive bladder cancer (MIBC) undergoing different treatment methods.</p><p><strong>Design: </strong>Retrospective cross-sectional study.</p><p><strong>Setting: </strong>A secondary care, multicenter study in Kerman, Iran 2008 to 2016.</p><p><strong>Participants: </strong>All 200 patients who were diagnosed with Muscle Invasive Bladder Cancer and were admitted to our hospitals. Patients with inaccessible medical files and patients with pathologies other than TCC were excluded.</p><p><strong>Main outcome measures: </strong>Radical cystectomy and different methods of bladder preservation were compared based on their survival rate.</p><p><strong>Interventions: </strong>Radical cystectomy or bladder preservation.</p><p><strong>Results: </strong>Overall survival of the patients was 2 years [95% CI: 1.37-2.63]. The overall 5-year survival rate of patients with MIBC was 32%. Having a 6.4 years overall survival, the RC group showed the highest survival compared with others (<i>p</i> = 0.01); the overall survival of patients undergoing TMT, TURT, chemotherapy, or radiotherapy monotherapy was 3.15 years [95% CI: 2.242-4.061], 4.06 [95% CI: 3.207-4.931], 2.58 [95% CI: 1.767-3.399], and 3.14 [95% CI: 1.614-4.672] years, respectively. Patients younger than 65 undergoing RC had an overall survival of 7 years, compared with 2 years for the TMT group. (<i>p</i> = 0.0001).</p><p><strong>Conclusions: </strong>The Bladder-Preservation method, as a replacement for RC, showed a lower overall survival rate in our study. A prospective randomized clinical trial may declare the best treatment.</p>","PeriodicalId":23574,"journal":{"name":"Urologia Journal","volume":" ","pages":"687-694"},"PeriodicalIF":0.8000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of the overall survival of different treatment methods in patients with Muscle-invasive bladder cancer: A retrospective study.\",\"authors\":\"Hamid Pakmanesh, Azadeh Khajehsalimi, Mohammadamin Hesamarefi, Mohamad Reza Ebadzadeh, Azam Bazrafshan, Reza Malekpourafshar, Mahboubeh Mirzaei, Azar Daneshpajouh, Armita Shahesmaeili, Nazanin Eslami\",\"doi\":\"10.1177/03915603241256009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Bladder-Sparing Approach was presented in patients who are not willing or not suitable for Radical Cystectomy (RC). There have been inconsistencies in the literature regarding the comparison of survival rates of these two methods. Our objective is to evaluate the survival rate of patients with muscle-invasive bladder cancer (MIBC) undergoing different treatment methods.</p><p><strong>Design: </strong>Retrospective cross-sectional study.</p><p><strong>Setting: </strong>A secondary care, multicenter study in Kerman, Iran 2008 to 2016.</p><p><strong>Participants: </strong>All 200 patients who were diagnosed with Muscle Invasive Bladder Cancer and were admitted to our hospitals. Patients with inaccessible medical files and patients with pathologies other than TCC were excluded.</p><p><strong>Main outcome measures: </strong>Radical cystectomy and different methods of bladder preservation were compared based on their survival rate.</p><p><strong>Interventions: </strong>Radical cystectomy or bladder preservation.</p><p><strong>Results: </strong>Overall survival of the patients was 2 years [95% CI: 1.37-2.63]. The overall 5-year survival rate of patients with MIBC was 32%. Having a 6.4 years overall survival, the RC group showed the highest survival compared with others (<i>p</i> = 0.01); the overall survival of patients undergoing TMT, TURT, chemotherapy, or radiotherapy monotherapy was 3.15 years [95% CI: 2.242-4.061], 4.06 [95% CI: 3.207-4.931], 2.58 [95% CI: 1.767-3.399], and 3.14 [95% CI: 1.614-4.672] years, respectively. Patients younger than 65 undergoing RC had an overall survival of 7 years, compared with 2 years for the TMT group. (<i>p</i> = 0.0001).</p><p><strong>Conclusions: </strong>The Bladder-Preservation method, as a replacement for RC, showed a lower overall survival rate in our study. A prospective randomized clinical trial may declare the best treatment.</p>\",\"PeriodicalId\":23574,\"journal\":{\"name\":\"Urologia Journal\",\"volume\":\" \",\"pages\":\"687-694\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urologia Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/03915603241256009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/12 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologia Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/03915603241256009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/12 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:针对不愿意或不适合接受根治性膀胱切除术(RC)的患者,提出了保留膀胱的方法。关于这两种方法的存活率比较,文献中存在不一致之处。我们的目的是评估接受不同治疗方法的肌层浸润性膀胱癌(MIBC)患者的生存率:设计:回顾性横断面研究:2008年至2016年在伊朗克尔曼进行的一项二级护理多中心研究:所有 200 名被诊断为肌浸润性膀胱癌并在本医院住院治疗的患者。主要结果指标:根据生存率比较根治性膀胱切除术和不同的膀胱保留方法:干预措施:根治性膀胱切除术或膀胱保留术:患者的总生存期为2年[95% CI:1.37-2.63]。MIBC患者的5年总生存率为32%。RC组的总生存期为6.4年,与其他组相比生存期最高(P = 0.01);接受TMT、TURT、化疗或放疗单药治疗的患者的总生存期分别为3.15年[95% CI:2.242-4.061]、4.06年[95% CI:3.207-4.931]、2.58年[95% CI:1.767-3.399]和3.14年[95% CI:1.614-4.672]。接受 RC 治疗的 65 岁以下患者的总生存期为 7 年,而接受 TMT 治疗的患者的总生存期为 2 年。(P=0.0001):结论:在我们的研究中,膀胱保存法作为 RC 的替代方法,总生存率较低。前瞻性随机临床试验可能会确定最佳治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comparison of the overall survival of different treatment methods in patients with Muscle-invasive bladder cancer: A retrospective study.

Objectives: Bladder-Sparing Approach was presented in patients who are not willing or not suitable for Radical Cystectomy (RC). There have been inconsistencies in the literature regarding the comparison of survival rates of these two methods. Our objective is to evaluate the survival rate of patients with muscle-invasive bladder cancer (MIBC) undergoing different treatment methods.

Design: Retrospective cross-sectional study.

Setting: A secondary care, multicenter study in Kerman, Iran 2008 to 2016.

Participants: All 200 patients who were diagnosed with Muscle Invasive Bladder Cancer and were admitted to our hospitals. Patients with inaccessible medical files and patients with pathologies other than TCC were excluded.

Main outcome measures: Radical cystectomy and different methods of bladder preservation were compared based on their survival rate.

Interventions: Radical cystectomy or bladder preservation.

Results: Overall survival of the patients was 2 years [95% CI: 1.37-2.63]. The overall 5-year survival rate of patients with MIBC was 32%. Having a 6.4 years overall survival, the RC group showed the highest survival compared with others (p = 0.01); the overall survival of patients undergoing TMT, TURT, chemotherapy, or radiotherapy monotherapy was 3.15 years [95% CI: 2.242-4.061], 4.06 [95% CI: 3.207-4.931], 2.58 [95% CI: 1.767-3.399], and 3.14 [95% CI: 1.614-4.672] years, respectively. Patients younger than 65 undergoing RC had an overall survival of 7 years, compared with 2 years for the TMT group. (p = 0.0001).

Conclusions: The Bladder-Preservation method, as a replacement for RC, showed a lower overall survival rate in our study. A prospective randomized clinical trial may declare the best treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Urologia Journal
Urologia Journal UROLOGY & NEPHROLOGY-
CiteScore
0.60
自引率
12.50%
发文量
66
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信